|
ZNF639 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.72906175225307E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.71405120599866E-12 |
| Normal-vs-Stage2 |
6.33070040834127E-10 |
| Normal-vs-Stage3 |
5.4722892883774E-13 |
| Normal-vs-Stage4 |
2.24131824211327E-12 |
| Stage1-vs-Stage2 |
8.919200E-01 |
| Stage1-vs-Stage3 |
4.562800E-01 |
| Stage1-vs-Stage4 |
4.274000E-01 |
| Stage2-vs-Stage3 |
5.663800E-01 |
| Stage2-vs-Stage4 |
4.863600E-01 |
| Stage3-vs-Stage4 |
8.483000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77657888400518E-12 |
| Normal-vs-AfricanAmerican |
7.86440000000166E-05 |
| Normal-vs-Asian |
5.52180523527568E-11 |
| Caucasian-vs-AfricanAmerican |
2.696500E-02 |
| Caucasian-vs-Asian |
3.120400E-01 |
| AfricanAmerican-vs-Asian |
2.006800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.58391094579247E-12 |
| Normal-vs-Female |
6.82010004027234E-13 |
| Male-vs-Female |
8.860400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.17081908004957E-12 |
| Normal-vs-Age(41-60Yrs) |
3.63797880709171E-12 |
| Normal-vs-Age(61-80Yrs) |
4.01900734914307E-12 |
| Normal-vs-Age(81-100Yrs) |
6.793800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.803600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.666800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.790000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.677000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.785800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.343000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.168600E-01 |
| Classical-VS-Follicular |
7.571400E-01 |
| Classical-VS-Other |
8.670600E-01 |
| Classical-VS-Normal |
2.26200169706203E-11 |
| Tall-VS-Follicular |
4.242200E-01 |
| Tall-VS-Other |
6.619400E-01 |
| Tall-VS-Normal |
5.19909670870788E-11 |
| Follicular-VS-Other |
9.676200E-01 |
| Follicular-VS-Normal |
7.04509783844287E-11 |
| Other-VS-Normal |
2.423300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79389836318933E-12 |
| Normal-vs-N1 |
1.70075065142328E-12 |
| N0-vs-N1 |
3.234600E-01 |
|
|
